The Ca2+-Activated K+ Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy
出版年份 2013 全文链接
标题
The Ca2+-Activated K+ Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 11, Pages e81006
出版商
Public Library of Science (PLoS)
发表日期
2013-11-30
DOI
10.1371/journal.pone.0081006
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium-dependent Signaling
- (2013) Dan Bi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ca2+-Activated K+Channel–3.1 Blocker TRAM-34 Attenuates Airway Remodeling and Eosinophilia in a Murine Asthma Model
- (2012) Pierre-Olivier Girodet et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- NS6180, a new KCa3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease
- (2012) D Strøbaek et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
- (2012) Kate Lykke Lambertsen et al. PLoS One
- Significant Reduction of Acute Cardiac Allograft Rejection by Selective Janus Kinase-1/3 Inhibition Using R507 and R545
- (2012) Tobias Deuse et al. TRANSPLANTATION
- The Potassium Channel KCa3.1 as New Therapeutic Target for the Prevention of Obliterative Airway Disease
- (2012) Xiaoqin Hua et al. TRANSPLANTATION
- Kv1.3 channels as a potential target for immunomodulation of CD4+CD28null T cells in patients with acute coronary syndrome
- (2011) Rende Xu et al. CLINICAL IMMUNOLOGY
- Diverse morphologic manifestations of cardiac allograft vasculopathy: A pathologic study of 64 allograft hearts
- (2011) Wei-hui Lu et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- KV1.3
- (2010) William F. Jackson ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Characterization of Ion Channels Involved in the Proliferative Response of Femoral Artery Smooth Muscle Cells
- (2010) Pilar Cidad et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers
- (2010) Alex Cheong et al. CARDIOVASCULAR RESEARCH
- Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis
- (2010) L. Di et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic potential of KCa3.1 blockers: recent advances and promising trends
- (2010) Heike Wulff et al. Expert Review of Clinical Pharmacology
- Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes
- (2009) Sergey G. Baryshnikov et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension
- (2009) Sebastian Brähler et al. CIRCULATION
- The functional network of ion channels in T lymphocytes
- (2009) Michael D. Cahalan et al. IMMUNOLOGICAL REVIEWS
- Voltage-gated potassium channels as therapeutic targets
- (2009) Heike Wulff et al. NATURE REVIEWS DRUG DISCOVERY
- Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels
- (2009) I. Grgic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention and Inhibition But Not Reversion of Chronic Allograft Vasculopathy by FK778
- (2009) Tobias Deuse et al. TRANSPLANTATION
- Blockade of T-Lymphocyte KCa3.1 and Kv1.3 Channels as Novel Immunosuppression Strategy to Prevent Kidney Allograft Rejection
- (2009) I. Grgic et al. TRANSPLANTATION PROCEEDINGS
- Local Delivery of the K Ca 3.1 Blocker, TRAM-34, Prevents Acute Angioplasty-Induced Coronary Smooth Muscle Phenotypic Modulation and Limits Stenosis
- (2008) D.L. Tharp et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
- (2008) K. I. Ataga et al. BLOOD
- K+Channel Modulators for the Treatment of Neurological Disorders and Autoimmune Diseases
- (2008) Heike Wulff et al. CHEMICAL REVIEWS
- The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans
- (2008) Kazuyoshi Toyama et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now